Qualcomm Inc: Form 10-Q for the period ended Mar 26, 2023
Filed with the SEC on May 3, 2023 and accepted by EDGAR at May 3, 2023, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-26. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-12-26 to 2023-03-26 | $9.28bn | us-gaap:Revenues |
| Revenue | 6 months2022-09-26 to 2023-03-26 | $18.74bn | us-gaap:Revenues |
| Cost of revenue | 3 months2022-12-26 to 2023-03-26 | $4.15bn | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2022-09-26 to 2023-03-26 | $8.20bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2022-12-26 to 2023-03-26 | $2.21bn | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-09-26 to 2023-03-26 | $4.46bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-12-26 to 2023-03-26 | $614.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-09-26 to 2023-03-26 | $1.24bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-12-26 to 2023-03-26 | $2.09bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-09-26 to 2023-03-26 | $4.55bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-12-26 to 2023-03-26 | $179.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-09-26 to 2023-03-26 | $348.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-12-26 to 2023-03-26 | $193.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-09-26 to 2023-03-26 | $291.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-12-26 to 2023-03-26 | $1.70bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-09-26 to 2023-03-26 | $3.94bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-12-26 to 2023-03-26 | $1.52 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-09-26 to 2023-03-26 | $3.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-12-26 to 2023-03-26 | $1.53 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-09-26 to 2023-03-26 | $3.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-12-26 to 2023-03-26 | 1,123,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-09-26 to 2023-03-26 | 1,127,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-09-26 to 2023-03-26 | $4.55bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-09-26 to 2023-03-26 | $851.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 6 months2022-09-26 to 2023-03-26 | $2.17bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-03-26 | $3.49bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-26 | $19.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-26 | $48.36bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-26 | $7.87bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-26 | $28.66bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-26 | $15.49bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2023-03-26 | $499.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-03-26 | $19.70bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0000804328-23-000023. Last ingested by Listed: Nov 4, 2026, 20:36 ET. Listed shows no prices and gives no investment advice.